Healthcare & Life Sciences

Kivu Bioscience

Kivu Bioscience is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.

activeseries-a
series-a
Stage
2018
Founded
1
Investors

About Kivu Bioscience

Kivu Bioscience is a company founded in 2018 headquartered in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Kivu Bioscience is a clinical-stage biotechnology company developing next-generation antibody-drug conjugates (ADCs) for oncology, utilizing proprietary GlycoConnect technology to improve stability and reduce off-target toxicity.

Explore Kivu Bioscience's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in United States